Mark Cobbold
Research Projects
Metabolic characterisation of machine-perfused kidneys
Christian Ludwig, , Daniel Tennant & Mark Cobbold
ROYAL COLLEGE OF SURGEONS
9/02/15 → 8/02/16
Project: Research
Advancement of a Clinical Development Candidate for Redirecting Viral Immunity against cancer
REVITOPE LTD
26/11/14 → 25/11/15
Project: Industry
The commercialisation of a novel "label free" cell separation technology
BIOTECHNOLOGY & BIOLOGICAL SCIENCES
1/11/14 → 31/01/15
Project: Research Councils
Generation of induced pluripotent stem cells for novel cell therapies
Mark Cobbold, Graham Anderson & Paloma Garcia
THE WELLCOME TRUST
1/10/13 → 30/09/16
Project: Research
Redirected Viral Immunotherapy for Acute Myeloid Leukaemia
Mark Cobbold, Sylvie Freeman, Pamela Kearns & Victoria Weston
BLOODWISE
9/09/13 → 8/09/16
Project: Research
MRC CIC - Advancing a generic scalable chromatography separation medical device for therapeutic cells.
Mark Cobbold & Oliver Goodyear
MEDICAL RESEARCH COUNCIL
4/09/13 → 30/06/16
Project: Research Councils
Redirected Immunotherapy Using Viral Epitope Conjugated Antibodies
Cancer Research UK
1/01/13 → 30/04/15
Project: Research
Antigen Receptor Diversity and Autoantibody Characterisation in Common Variable Immunodeficiency
Gabriel Wong, Mark Cobbold & Peter Lane
THE WELLCOME TRUST
1/10/12 → 30/09/15
Project: Research
Characterising and Immunologically Targeting the Phosphoproteome in Myeloid Leukaemia
Mark Cobbold, Charles Craddock, Sylvie Freeman & Manoj Raghavan
BLOODWISE
1/10/12 → 30/09/16
Project: Research
Additional Sponsorship 2011 - Shaping Capability BTG - Retargeting Tumour Cells Using a Synthetic Biology Approach
Mark Cobbold, Paula Mendes, Anna Peacock & Peter Winn
ENGINEERING & PHYSICAL SCIENCE RESEARCH COUNCIL
1/02/12 → 30/06/12
Project: Research
The Role of Biomarkers in Monitoring Renal Allograft Function
Mark Cobbold & Nicholas Inston
UHB CHARITABLE FUNDS
4/01/12 → 3/01/13
Project: Research
Developing generic scalable and standardised selection methods for human therapeutic cells BRIC
BIOTECHNOLOGY & BIOLOGICAL SCIENCES
1/09/11 → 30/09/14
Project: Research Councils
The Role Of Histone Deacetylases In Renal Transplantation
UHB CHARITABLE FUNDS
1/10/09 → 29/02/12
Project: Research
A Randomized Phase II Trial CMV Specific Adoptive Immunotherapy After Stem Cell Transplantation
Paul Moss, Frederick Chen, Mark Cobbold & Charles Craddock
BLOODWISE
1/02/09 → 31/08/14
Project: Research
Immune Targeting of the Phosphoproteome in Chronic Lymphocytic Leukaemia
Mark Cobbold, Dickens Pratt & Tatjana Stankovic
THE KAY KENDAL LEUKAEMIA FUND
12/01/09 → 31/05/12
Project: Research
Characterising and Immunologically Targeting the Phosphoproteome in Acute Myeloid Leukaemia
Mark Cobbold, & Sylvie Freeman
BLOODWISE
24/11/08 → 31/03/12
Project: Research
Immune Trageting of the Leukaemia/Lymphoma Phosphoproteome
UHB CHARITABLE FUNDS
1/10/08 → 30/09/11
Project: Research
Adoptive T Cell Immunotherapy Therapy for Adenovirus Infection in Transplant Patients
Paul Moss, Mark Cobbold & Vivien Mautner
MEDICAL RESEARCH COUNCIL
1/04/07 → 31/08/10
Project: Research Councils
The Development of Cellular Therapy for the Correction of CMV-Specific Immunodeficiency After Stem Cell Transplantation
MEDICAL RESEARCH COUNCIL
1/07/03 → 31/07/09
Project: Research Councils
Direct Selection and Adoptive Transfer of Cytomegalovirus-specific Cytotoxic T Cells into Patients Undergoing Stem Cell Transplantation.
MEDICAL RESEARCH COUNCIL
1/04/00 → 31/03/03
Project: Research Councils